X4 Pharmaceuticals Cash Flow Statement (2018-2025) | XFOR

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -6.21M-6.48M-8.64M-8.24M-10.87M-13.38M-17.71M-10.84M-11.14M-15.14M-17.45M-18.40M-18.68M-19.64M-20.18M-30.21M-21.96M-21.21M-21.59M-29.10M-24.02M-55.71M-2.31M-19.13M-51.77M90.83M-36.70M-39.82M0.28M-25.74M-29.82M
Depreciation and Depletion 0.10M0.06M0.07M0.08M0.29M0.17M
Share-based Compensation 0.13M1.05M1.07M0.29M0.26M0.43M0.69M0.66M0.61M1.17M2.24M1.40M1.26M1.80M1.52M1.61M1.46M1.52M1.11M1.11M1.65M2.14M2.36M2.54M1.74M2.43M1.82M2.22M0.52M0.75M0.76M
Gains from Investment Securities 2.11M2.10M2.05M1.94M1.17M-0.07M0.10M4.62M-4.23M1.34M0.12M0.17M-0.55M0.22M-5.44M29.86M-25.16M0.97M0.12M0.16M0.22M0.14M0.17M-0.37M0.15M
Non-cash Items 27.36M0.18M0.05M7.17M
Cash from Operations -6.18M-5.78M-6.72M-6.73M-11.75M-14.29M-12.77M-9.24M-15.53M-11.46M-14.33M-17.50M-18.44M-19.20M-14.21M-19.05M-20.23M-18.47M-19.31M-19.09M-26.51M-47.90M-68.80M-27.75M-33.60M-63.90M-34.03M-32.99M-12.40M-29.90M-27.80M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.03M0.03M0.03M0.03M0.02M0.02M0.03M0.03M0.04M0.07M0.15M0.10M0.11M0.13M0.13M0.13M0.13M0.13M0.12M0.12M0.13M0.13M0.10M0.06M0.06M0.19M0.27M0.27M0.48M0.35M0.22M
Change in Working Capital
Change in Receivables -0.28M-0.36M-0.72M-0.02M3.00M1.07M-0.56M0.64M-0.25M
Change in Inventory 0.83M1.61M0.37M0.27M0.08M0.91M
Change in Account Payables -0.56M-0.04M0.81M1.10M1.33M-3.03M-1.43M0.38M-0.80M0.59M0.33M0.91M-0.02M-0.57M-0.10M1.86M-0.71M0.11M0.12M3.91M-1.71M-1.10M3.24M0.81M0.00M-0.95M0.58M0.08M2.48M-3.44M-2.65M
Change in Accured Expenses 0.24M0.21M0.72M0.38M-2.07M0.92M0.56M0.76M-0.67M2.21M0.18M-0.20M-0.79M-0.07M1.92M-1.22M-0.98M1.64M0.65M2.50M0.50M4.53M0.63M-4.04M1.26M2.74M-0.17M3.34M-7.78M0.23M3.37M
Investing Activities
Capital Expenditures -0.03M0.01M0.08M0.08M0.56M0.01M1.49M-0.69M0.50M0.09M0.02M0.01M0.02M0.04M0.01M0.03M0.01M0.01M0.01M0.04M0.06M3.44M-3.17M
Change in Intangibles 0.10M
Acquisitions -26.41M52.81M
Change in Acquisitions & Divestments 1.00M1.00M5.00M2.00M5.25M14.20M11.75M28.18M15.87M
Cash from Investing Activities 0.03M26.41M-0.01M0.81M0.02M-0.56M-0.01M-0.50M-0.30M-0.50M-0.09M-0.02M-0.01M-0.02M-0.04M-0.01M-0.03M-0.01M-4.88M-5.16M-4.83M-5.32M96.86M-15.93M-8.62M-3.14M23.11M-28.67M
Financing Activities
Other financing activities 0.04M
Debt Issuance and Repayment
Long-Term Debt Issuances 5.45M9.85M4.89M7.50M22.50M
Long-Term Debt Repayments 0.50M0.50M0.50M4.88M6.45M
Change in Capital Stock
Shares Issued 0.11M0.45M0.04M0.19M0.10M0.08M0.29M0.09M0.04M0.12M0.10M0.07M0.14M0.00M0.10M0.14M86.91M
Shares Repurchased 0.44M
Misc.
Cash from Financing Activities -1.66M-0.49M4.00M5.03M0.11M86.68M-6.41M60.28M4.98M0.07M-0.28M7.63M55.04M-0.92M-4.44M24.57M4.96M-0.35M51.98M60.64M-2.12M69.34M21.20M0.10M20.16M0.14M5.63M86.91M
Exchange Rate Effect 0.02M-0.14M0.12M-0.02M0.02M-0.26M0.02M-0.03M0.09M0.18M0.16M-0.14M0.04M-0.10M-0.12M-0.07M-0.20M-0.20M0.36M0.05M-0.01M-0.07M0.13M-0.06M-0.02M0.17M-0.24M0.07M0.14M-0.00M
Change in Cash -7.84M-6.28M-2.73M-1.71M14.75M72.39M-18.64M51.08M-11.13M-11.31M-14.93M-10.02M35.96M-20.17M-18.77M5.39M-15.36M-19.06M32.47M41.88M-28.59M43.02M-4.85M-32.36M-38.98M86.73M-49.80M-41.73M-15.43M-1.02M30.41M
Free Cash Flow -6.18M-5.78M-6.69M-6.73M-11.75M-14.30M-12.85M-9.32M-16.08M-11.47M-15.82M-16.81M-18.94M-19.28M-14.23M-19.07M-20.25M-18.51M-19.32M-19.13M-26.52M-47.91M-68.81M-27.78M-33.66M-67.34M-34.03M-29.82M-12.40M-29.90M-27.80M
Net Cash Flow -7.84M-6.28M-2.70M-1.71M14.77M72.38M-18.37M51.06M-11.10M-11.40M-15.11M-10.18M36.10M-20.21M-18.67M5.50M-15.29M-18.86M32.66M41.52M-28.64M16.55M-52.75M-32.48M-38.92M53.12M-49.96M-41.48M-15.54M-1.16M30.44M